Atom Investors LP Kamada LTD Transaction History

Atom Investors LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$6.02 - $8.06 $64,395 - $86,217	-10,697 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$6.3 - $8.46 $419,970 - $563,960	-66,662 Reduced 86.17%	10,697 $69,000
Q3 2020 Nov 13, 2020	SELL	$8.02 - $11.73 $181,580 - $265,578	-22,641 Reduced 22.64%	77,359 $647,000
Q2 2020 Aug 14, 2020	BUY	$5.37 - $9.45 $537,000 - $944,999	100,000 New	100,000 $776,000

6.48M

200

Ticker KMDA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 44,800,500
Market Cap $332M
Description
Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

Stay updated on Atom Investors LP with notifications on news.